UnitedHealth

UnitedHealth (UNH): Stock, Financials, Earnings & Company Overview

Quick answer: UnitedHealth Group (NYSE: UNH) is the largest health insurer in the United States and one of the largest health care companies in the world, built around two complementary businesses: UnitedHealthcare, its insurance arm, and Optum, its health services and pharmacy benefits arm. Headquartered in Minnetonka, Minnesota, the company generated $447.6 billion in revenue in 2025, though net income fell to about $12.1 billion as rising medical costs and Medicare Advantage pressures squeezed margins. As of early July 2026, UNH trades near $425 a share, a sharp rebound from its 2025 low near $235 but still well below its late 2024 all time high above $630. Stephen Hemsley, who previously led the company from 2006 to 2017, returned as CEO in May 2025 amid a period of intense scrutiny, including government investigations, cost pressures, and the fallout from the killing of UnitedHealthcare’s former CEO in December 2024, and is now leading a turnaround focused on repricing, cost discipline, and rebuilding investor trust.

Quick Facts

TickerUNH (New York Stock Exchange)
Sector / IndustryHealth Care, Managed Health Care and Health Insurance Plans
Founded1977, as Charter Med Incorporated; renamed United HealthCare Corporation in 1988 and UnitedHealth Group in 1998
FounderRichard T. Burke
HeadquartersMinnetonka, Minnesota, United States
Chief Executive OfficerStephen J. Hemsley
EmployeesApproximately 390,000 worldwide
Stock price (early July 2026)Around $425 per share
Market capitalizationRoughly $386 billion
52 week range$234.60 to $430.20
2025 revenue$447.6 billion
2025 net incomeAbout $12.1 billion ($13.23 diluted EPS)
Dividend yieldApproximately 2.2 percent
Next earnings dateJuly 16, 2026 (second quarter 2026)

What Is UnitedHealth?

UnitedHealth Group Incorporated is an American health care and insurance company that operates through two distinct but connected businesses. UnitedHealthcare provides health benefit plans, including employer coverage, Medicare Advantage, Medicaid managed care, and individual marketplace plans, to tens of millions of Americans. Optum, its health services arm, delivers care directly through clinics and physician groups, manages pharmacy benefits through Optum Rx, and provides data, technology, and consulting services to hospitals and health systems through Optum Insight.

UnitedHealth is the largest health insurer in the United States by both revenue and membership, and it is regularly ranked among the largest companies in the country by total revenue. UNH trades on the New York Stock Exchange and is a component of the Dow Jones Industrial Average and the S&P 500. Because it combines an insurance business with a large scale care delivery and pharmacy business under one roof, UnitedHealth is often described as a vertically integrated health care conglomerate rather than a traditional insurer.

Company History

UnitedHealth Group’s roots go back to 1977, when Richard T. Burke founded Charter Med Incorporated in Minnetonka, Minnesota, to manage one of the country’s first health maintenance organizations. The company reorganized in 1977 as United HealthCare Corporation and went public in 1984. Through the 1980s and 1990s it expanded rapidly by acquiring regional health plans and diversifying beyond a single HMO model into a broader family of insurance products.

A pivotal shift came in 1998, when the company renamed itself UnitedHealth Group and restructured around a portfolio of businesses that would eventually become Optum, its data, pharmacy, and care delivery arm, alongside UnitedHealthcare, its insurance arm. Over the following two decades Optum grew through acquisitions in pharmacy benefit management, health analytics, and physician practices, transforming UnitedHealth from a pure insurer into one of the largest employers of physicians in the country.

The company’s more recent history has been turbulent. In February 2024, a cyberattack on Optum’s Change Healthcare claims processing unit disrupted payments across large parts of the U.S. health system for weeks. In December 2024, Brian Thompson, the chief executive of UnitedHealthcare, was killed in New York City, a tragedy that intensified public scrutiny of the health insurance industry generally and of UnitedHealth specifically. In 2025, rising medical costs, Medicare Advantage funding pressures, and a wave of regulatory attention led the company to abruptly change chief executives, suspend its financial guidance, and undertake a broad reset of pricing and cost management that continues into 2026.

Founders

UnitedHealth Group traces its founding to Richard T. Burke, who established Charter Med Incorporated in 1977 to manage a Minnesota health maintenance organization. Burke served as the company’s first chief executive and chairman as it grew from a single HMO manager into United HealthCare Corporation. While UnitedHealth Group’s modern structure, spanning insurance, pharmacy benefits, and care delivery, was built over decades by many subsequent executives, Burke is credited as the founding figure behind the company that became today’s UnitedHealth Group. Burke later became well known outside health care as the longtime owner of the NHL’s Minnesota Wild.

CEO

UnitedHealth Group’s Chief Executive Officer is Stephen J. Hemsley, who returned to the role in May 2025 after previously serving as CEO from 2006 to 2017. Hemsley, who joined the company as chief operating officer in 1997 and had continued to serve as board chairman after his first tenure as CEO, was brought back to steady the company following the abrupt departure of former CEO Andrew Witty. Witty, who led UnitedHealth through the Change Healthcare cyberattack and the killing of UnitedHealthcare’s Brian Thompson, stepped down for personal reasons as the company confronted higher than expected medical costs and suspended its 2025 financial guidance.

Since returning, Hemsley has pushed a message of returning to fundamentals: tighter underwriting and pricing discipline, cost reductions supported by artificial intelligence, and a renewed focus on the historical 13 to 16 percent long term earnings growth target. Tim Noel leads the UnitedHealthcare insurance business and Dr. Patrick Conway leads Optum, both reporting into Hemsley as part of the leadership reset.

Headquarters

UnitedHealth Group is headquartered at 9900 Bren Road East in Minnetonka, Minnesota, a suburb of Minneapolis, at a campus known as the UnitedHealth Group Center. The company also maintains a large corporate presence nearby in Eden Prairie, Minnesota, home to much of the Optum organization, and operates offices and facilities across the United States and in a number of other countries where Optum and UnitedHealthcare do business.

Business Segments

UnitedHealth Group reports results across four primary segments:

  • UnitedHealthcare, the insurance business, split into UnitedHealthcare Employer and Individual (commercial coverage for businesses and individuals), UnitedHealthcare Medicare and Retirement (Medicare Advantage and Medicare supplement plans for seniors), and UnitedHealthcare Community and State (Medicaid managed care).
  • Optum Health, which delivers direct patient care through owned medical groups, ambulatory surgery centers, and value based care arrangements that pay providers based on patient outcomes rather than volume of services.
  • Optum Insight, which sells software, data analytics, revenue cycle management, and consulting services to hospitals, physician groups, health plans, and life sciences companies.
  • Optum Rx, a pharmacy benefit manager that negotiates drug pricing, processes prescription claims, and runs home delivery and specialty pharmacy services for health plans, employers, and government programs.

Optum Health, Optum Insight, and Optum Rx are collectively referred to as Optum. A meaningful share of Optum’s revenue comes from serving UnitedHealthcare’s own members, which is eliminated in consolidation, so the sum of segment revenues is larger than UnitedHealth’s total reported revenue.

Products and Services

  • Employer and individual health plans: Fully insured and self funded medical coverage for large national employers, mid sized businesses, small groups, and individuals, including plans sold on ACA marketplaces.
  • Medicare Advantage and Medicare Supplement plans: Private Medicare plans for seniors and people with disabilities, marketed under the UnitedHealthcare and AARP branded Medicare Supplement lines.
  • Medicaid managed care: State contracted health plans for low income individuals and families, and for people with complex or long term care needs, across dozens of states.
  • Care delivery: Primary care, multispecialty, surgical, and behavioral health services delivered through Optum owned clinics and affiliated physician groups.
  • Pharmacy benefit management: Optum Rx negotiates with drug manufacturers, manages formularies, and operates home delivery and specialty pharmacy for health plan and employer clients.
  • Health information technology and analytics: Optum Insight’s software and consulting services, including claims processing, revenue cycle management, and clinical data analytics for hospitals and health systems.

Revenue Breakdown

UnitedHealth Group generated total consolidated revenue of $447.6 billion in 2025, up 12 percent from 2024. On a gross segment basis before intersegment eliminations, UnitedHealthcare brought in $344.9 billion, up 16 percent, while Optum’s businesses combined for $270.6 billion, up 7 percent.

2025 Segment Revenue, UnitedHealthcare vs. Optum (gross, before eliminations)

UnitedHealthcare $344.9B (56%) Optum $270.6B (44%)

Source: UnitedHealth Group full year 2025 earnings release. Percentages are of the combined gross segment total, not of consolidated company revenue, since Optum revenue earned from serving UnitedHealthcare members is eliminated in consolidation.

Optum business line2025 revenueChange vs. 2024
Optum Rx (pharmacy benefits)$154.7 billionUp 16 percent
Optum Health (care delivery)$102.0 billionDown 3 percent
Optum Insight (data and analytics)$19.4 billionUp 4 percent

Within UnitedHealthcare, the Community and State Medicaid business grew fastest, up 17 percent to $94.4 billion in 2025, while the core Employer and Individual commercial business grew more modestly to $79.2 billion. Optum Rx was the standout growth engine across the entire company in 2025, benefiting from new pharmacy benefit clients and continued script volume growth, while Optum Health’s revenue actually declined as the company deliberately pulled back the pace of new value based care patient additions to improve execution.

Financial Performance

UnitedHealth’s revenue has grown every year for more than a decade, but profitability has moved in the opposite direction since 2023 as Medicare funding reductions, higher medical utilization, and pricing that lagged rising costs squeezed margins.

Revenue and Net Income, 2022 to 2025

2022 2023 2024 2025 $324B $372B $400B $448B
Total annual revenue (bars) Net income (line)

Net income by year: 2022 about $20.1B, 2023 $22.4B, 2024 about $14.4B, 2025 about $12.1B. Source: UnitedHealth Group annual earnings releases and SEC filings. Note how net income and revenue moved in opposite directions after 2023, reflecting rising medical costs and Medicare funding pressure.

Metric20242025
Revenue$400.3 billion$447.6 billion
Net incomeAbout $14.4 billionAbout $12.1 billion
Diluted EPS$15.51$13.23
Adjusted EPS$27.66$16.35
Net marginAround 3.6 percent2.7 percent
Cash flow from operations$24.2 billion$19.7 billion

The large gap between reported and adjusted earnings per share in recent years mostly reflects one time items, including costs related to the Change Healthcare cyberattack response and other significant charges that the company excludes from its adjusted figures. First quarter 2026 results showed signs of stabilization, with revenue of $111.7 billion, up 2 percent year over year, and adjusted earnings per share of $7.23, supporting full year 2026 guidance of adjusted net earnings above $18.25 per share as the company works to restore its historical growth rate.

Stock Information

UNH shares have been on a volatile multi year ride. The stock reached an all time closing high above $630 in November 2024, then fell roughly 60 percent to a low near $235 in August 2025 as cost pressures, the leadership change, and regulatory headlines weighed on sentiment. Since that low, UNH has staged a strong recovery, rising more than 80 percent as investors have grown more confident in the Hemsley led turnaround and in 2026 earnings guidance.

52 Week Trading Range

52 week low: $234.60 52 week high: $430.20 Current ~$425

Range and price data as of early July 2026. Analyst price targets vary widely, from a low near $287 to a high near $492, reflecting the ongoing debate about how quickly medical cost trends and Medicare Advantage margins will normalize.

Recent priceApproximately $425
Market capAbout $386 billion
52 week range$234.60 to $430.20
All time closing high$630.73 (November 2024)
Price to earnings (TTM)Around 32
Trailing EPS$13.23 to $13.25
BetaAbout 1.25
Total stock splitsFive since UnitedHealth’s public listing

UNH’s beta near 1.25 means the stock has typically moved somewhat more than the overall market, and the past two years have been an unusually sharp example of that, with the stock roughly halving and then rebounding by a similar magnitude in a span of about 12 months. Analyst opinion has grown more constructive after a series of price target increases in mid 2026, though the wide range of targets shows real disagreement about the pace of margin recovery.

Dividends

UnitedHealth has paid and raised its dividend every year for more than 15 consecutive years, even through its recent earnings turbulence. In June 2026 the board approved a 5 percent increase in the quarterly dividend, from $2.21 to $2.32 per share, marking the company’s 16th consecutive annual increase, though a smaller one than the double digit hikes typical of the prior decade.

Dividend metricValue
Quarterly dividend per share$2.32
Annualized dividend$9.28
Trailing dividend yieldAbout 2.2 percent
Payout ratioRoughly 66 percent of trailing earnings
2025 shareholder returnsMore than $13 billion combined in dividends and share repurchases

The smaller size of the latest dividend increase reflects the pressure on earnings over the past two years, but the fact that the board kept raising the payout at all during one of the most difficult stretches in the company’s history is seen by many income investors as a signal of confidence in the underlying cash flow of the business. UnitedHealth also continued meaningful share repurchases through the downturn, spending billions of dollars buying back stock even as shares traded well below their prior highs.

Competitors

  • CVS Health, owner of Aetna and the CVS Caremark pharmacy benefit manager, competing directly with UnitedHealthcare and Optum Rx.
  • Cigna Group, a major national health insurer and owner of the Express Scripts pharmacy benefit manager.
  • Elevance Health, formerly Anthem, one of the largest Blue Cross Blue Shield affiliated insurers in the country.
  • Humana, a leading competitor in Medicare Advantage, UnitedHealthcare’s largest and most profitable line of business.
  • Centene and Molina Healthcare, both focused heavily on Medicaid managed care and ACA marketplace plans.
  • Kaiser Permanente, a large nonprofit integrated health system and insurer that competes regionally, particularly on the West Coast.

UnitedHealth’s combination of a large national insurer with an in house pharmacy benefit manager and a growing physician and clinic network through Optum makes its competitive position somewhat different from pure play insurers, since it competes with hospital systems and pharmacy benefit managers as well as with other health plans.

Recent News

Dividend increase and buybacks. In June 2026, UnitedHealth’s board raised the quarterly dividend 5 percent to $2.32 per share and reaffirmed plans to continue substantial share repurchases, signaling growing confidence in the turnaround under CEO Stephen Hemsley.
DOJ health care fraud sweep. In June 2026, the Department of Justice announced a broad $6.5 billion health care fraud enforcement sweep, part of continuing federal scrutiny of billing and coding practices across the Medicare Advantage industry that has included UnitedHealth in past reporting.
FTC insulin pricing settlement. UnitedHealth reached a tentative settlement with the Federal Trade Commission in June 2026 concerning insulin pricing practices tied to its Optum Rx pharmacy benefit business, part of a broader industry wide look at how pharmacy benefit managers negotiate drug prices.
Analyst upgrades following the rebound. As UNH shares recovered through the first half of 2026, several banks raised price targets, including Bank of America to $475 from $450 and Morgan Stanley to $468 from $453, reflecting improved confidence in 2026 earnings guidance after the first quarter beat.

Frequently Asked Questions

Is UnitedHealth a good stock to buy right now?

That depends on individual goals, risk tolerance, and time horizon, and this article is not financial advice. UnitedHealth offers scale, a diversified health services business through Optum, and a growing dividend, but the stock has been unusually volatile over the past two years and still faces regulatory scrutiny and medical cost pressure. Anyone considering an investment should review the company’s official filings and consider speaking with a licensed financial advisor.

Who founded UnitedHealth Group?

UnitedHealth Group traces back to Charter Med Incorporated, founded in 1977 by Richard T. Burke, which grew into United HealthCare Corporation and was renamed UnitedHealth Group in 1998.

Who is the CEO of UnitedHealth Group?

Stephen J. Hemsley is the current Chief Executive Officer, having returned to the role in May 2025 after previously serving as CEO from 2006 to 2017.

Where is UnitedHealth Group headquartered?

UnitedHealth Group is headquartered in Minnetonka, Minnesota, with a large additional corporate presence in nearby Eden Prairie, Minnesota, home to much of the Optum business.

Does UnitedHealth pay a dividend?

Yes. UnitedHealth pays a quarterly dividend, currently $2.32 per share, which annualizes to $9.28 and gives the stock a trailing dividend yield of roughly 2.2 percent. The company has raised its dividend for 16 consecutive years.

What are UnitedHealth’s main business segments?

UnitedHealth operates through UnitedHealthcare, its health insurance business, and three Optum segments, Optum Health, Optum Insight, and Optum Rx, which together provide care delivery, data and analytics services, and pharmacy benefit management.

Why did UnitedHealth stock fall so much in 2025?

UNH shares fell roughly 60 percent from their late 2024 peak due to a combination of higher than expected medical costs, particularly in Medicare Advantage, reduced government funding rates, an abrupt CEO change, suspended earnings guidance, and heightened regulatory and public scrutiny of the health insurance industry following the killing of UnitedHealthcare’s former CEO in December 2024.

How much revenue does UnitedHealth make each year?

UnitedHealth generated $447.6 billion in revenue in 2025, up from $400.3 billion in 2024 and $371.6 billion in 2023, continuing a long streak of annual revenue growth even as profit margins have come under pressure.

Who are UnitedHealth’s main competitors?

UnitedHealth’s primary competitors include CVS Health, Cigna Group, Elevance Health, Humana, Centene, and Molina Healthcare, along with large regional and nonprofit systems such as Kaiser Permanente.

When does UnitedHealth report earnings next?

UnitedHealth Group is scheduled to report second quarter 2026 results on July 16, 2026, though exact timing should always be confirmed through the company’s investor relations site closer to the date.

This article is for informational and educational purposes only and does not constitute financial, investment, or legal advice. Stock prices, financial figures, and analyst estimates change frequently and figures cited here reflect publicly available data as of early July 2026. Always verify current figures through UnitedHealth Group’s official investor relations site, SEC filings, or a live market data source, and consult a licensed financial advisor before making investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *